Companies: 10,795·Total market cap: $144.5T
Lumexa Imaging Holdings, Inc. Common Stock

Lumexa Imaging Holdings, Inc. Common Stock

LMRINASDAQHealthcare● Active
$8.02
$-0.48(-5.65%)
Market Cap$770567495
P/E Ratio
52W High$19.45
52W Low$6.45

Lumexa Imaging Holdings, Inc. Common Stock (LMRI) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

LMRI · net income · updated Jun 8, 2026

Core profitability metrics

Net income was −$47.1M for FY2025 (fiscal year ending 2025-12-31), up 49.9% year-over-year. Net profit margin was -4.6%.

FY2025 Net Income−$47.1M▲ +49.9% YoY
Trailing 12M (TTM)trailing 4 quarters sum
Net Profit Margin-4.6%−$47.1M ÷ $1.02B
YoY Change+49.9%
5-Year CAGRN/AN/A — contains loss years
FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0
Source: FMP /income-statement · US GAAP · USDUpdated: Jun 8, 2026

Annual net income history

Net IncomeNet LossNet Margin %

▸ FMP /income-statement · Annual · LMRI net income history · LMRI profit margin

Annual net income data

Fiscal YearNet IncomeYoY ChangeNet Margin
FY2025Loss−$47.1M▲ +49.9%-4.6%
FY2024Loss−$94.1M▲ +23.0%-9.9%
FY2023Loss−$122.2M-13.1%

Net income vs peers (Healthcare)

#CompanyNet IncomeYoY
#1
Lumexa Imaging Holdings, Inc. Common Stock
Lumexa Imaging Holdings, Inc. Common StockYOU
LMRI
−$47.1M+49.9%
#2
Johnson & Johnson
Johnson & Johnson
JNJ
$26.80B+90.6%
#3
Eli Lilly and Company
Eli Lilly and Company
LLY
$20.64B+94.9%
#4
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$12.06B-16.3%
#5
AbbVie Inc.
AbbVie Inc.
ABBV
$4.23B-1.2%
Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Lumexa Imaging Holdings, Inc. Common Stock (LMRI) reported net income of −$47.1M for FY2025 (fiscal year ending 2025-12-31), up 49.9% year-over-year. The net profit margin was -4.6% — meaning the company kept $-0.05 of every dollar of revenue as profit.

Lumexa Imaging Holdings, Inc. Common Stock has not yet achieved annual profitability based on available data (3 fiscal years). The company has reported net losses across all available periods.

Lumexa Imaging Holdings, Inc. Common Stock's net profit margin was -4.6% for FY2025, based on the latest annual results.

Investors sometimes search for "Lumexa Imaging Holdings, Inc. Common Stock net worth" — the company's market capitalization is a separate figure from LMRI net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Frequently asked questions

LMRI net income · 4 questions

Lumexa Imaging Holdings, Inc. Common Stock is not currently profitable on an annual basis. The company reported a net loss of $47.1M for FY2025.

is LMRI profitabledoes LMRI make a profitLMRI profitabilityLMRI profitable company

Source: FMP /income-statement · GAAP · Lumexa Imaging Holdings, Inc. Common Stock · Lumexa Imaging Holdings, Inc. Common Stock SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026